X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

eLife

期刊標題檢索 ELIFE 最新評論: 1: ESCI 2: No impact factor for 25 years, can't say about the zone ... (2025-03-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[eLife]您好,您是該頁面的第 317726 位訪客。

期刊簡介
期刊名稱eLife eLife
LetPub Score
8.4
51 ratings
Rate

Reputation
8.6

Influence
7.9

Speed
9.0

期刊簡稱ELIFE
ISSN2050-084X
h-index93
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.903.9321.613
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: General Neuroscience
Q112 / 113
Category: Neuroscience
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q124 / 221
Category: Neuroscience
Subcategory: General Immunology and Microbiology
Q18 / 61

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
eLife publishes work of the highest scientific standards and importance in all areas of the life and biomedical sciences. The research is selected and evaluated by working scientists and is made freely available to all readers without delay. eLife also invests in innovation through open-source tool development to accelerate research communication and discovery. Our work is guided by the communities we serve.
官方網站https://elifesciences.org/
在線稿件提交https://reviewer.elifesciences.org/login
開放訪問Yes
出版商eLife Sciences Publications
主題領域BIOLOGY
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數1332每年文章數趨勢
黃金OA百分比99.60%
OA Related Info
APC: Yes( USD3000; )
APC waiver:Check Notes
Other charges: No
Keywords: biomedicine、life sciences
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOLOGYSCIEQ18/109
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2050-084X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 17 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【eLife】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS MOLECULAR CELL BIOLOGYH-index: 386

    CiteScore: 173.60
    NATURE REVIEWS MICROBIOLOGYH-index: 250

    CiteScore: 74.00
    CELLH-index: 705

    CiteScore: 110.00
    NATURE REVIEWS GENETICSH-index: 320

    CiteScore: 57.40
    NATURE METHODSH-index: 257

    CiteScore: 58.70
    NATURE BIOTECHNOLOGYH-index: 399

    CiteScore: 63.00
    NATURE GENETICSH-index: 527

    CiteScore: 43.00
    CELL RESEARCHH-index: 143

    CiteScore: 53.90
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    FUNGAL DIVERSITYH-index: 80

    CiteScore: 44.80
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Plant Science942018
    Frontiers in Microbiology883657
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY863109
    PeerJ838699
    BIOSENSORS & BIOELECTRONICS755305
    FASEB JOURNAL711988
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS655070
    JOURNAL OF CELLULAR PHYSIOLOGY642250
    BMC GENOMICS509048
    NUCLEIC ACIDS RESEARCH488766
  •  

    eLife eLife
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/14)
  [eLife] 的評論撰寫評論
作者: 牛哥919


領域: 生物学
審稿時間: 12.0 month(s)
結果: 修改後接受


撰寫評論

2025-03-25 11:24:10 評論於
1: ESCI
2: No impact factor for 25 years, can't say about the zone of 26
3: If your paper has high completeness, it will be included, with a 97% inclusion rate
4: Payment is only required after submission for review, rejection means it was not submitted, and no payment is needed
(0) 讚! | 牛哥919

作者: 李炼师


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-21 15:44:48 評論於
Could you please tell me the current situation of Elfie (the zone announced by the Chinese Academy of Sciences at the end of March 2025)? Specifically, include the following:
1. Is it SCIE or ESCI? I want to submit an article but I'm afraid of wasting it.
2. Since there is no impact factor, how is the zone calculated by the Chinese Academy of Sciences? (From the above, it seems to still be in the first zone.)
3. It is also a concern that some articles are included (if my article is not included, even if it is in the first zone, it is not a scientific achievement).
4. I heard that you have to pay first and then get the result. If you pay and then get rejected, wouldn't that be very unfortunate?
(0) 讚! | 李炼师

作者: Lvpori


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2025-01-31 00:40:31 評論於
eLife has always been a journal that I really like, and I published an article here last year. Although it was embroiled in a public relations crisis at the end of last year, it cannot be denied that its open peer review and innovative publishing model still hold significant value for the academic community. The reason I am writing this comment today is because I have received another email from the new editor-in-chief, Dr. Tim Behrens, encouraging authors to continue submitting their work. In any case, eLife will still be one of the journals I consider for publication in the future.
(0) 讚! | Lvpori

作者: DrJhaha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-02 17:25:45 評論於
When the tide goes out, you can see who's been swimming naked.
(0) 讚! | DrJhaha

作者: hengheng12


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-06 16:10:09 評論於
There is a high probability that a journal put on hold will be removed from SCI, and the chance of being reinstated is very small.
(0) 讚! | hengheng12

作者: 留云一南


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 21:03:16 評論於
Latest news, the top journal in the first district of Chinese Academy of Sciences, the renowned life science journal eLife (IF 6.4), has been officially put "On hold" by Clarivate Analytics!
(0) 讚! | 留云一南

作者: 翻滚吧牛便便


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-10-28 21:36:44 評論於
Submit for review - pay layout fee - pre-print - external review, everything goes smoothly. Suddenly on hold on the 24th, received an email on the 28th saying they couldn't find enough reviewers and rejected my submission! Please help, what should I do with the article, what about the layout fee?!
(0) 讚! | 翻滚吧牛便便

作者: sci助理


領域: 医学
審稿時間: 7.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-25 16:19:20 評論於
It's on hold, really frustrating, all the good journals have been taken.
(2) 讚! | sci助理

作者: Vincent H.


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-25 10:00:52 評論於
How about flipping the table, abandoning Clarivate Analytics, and choosing another database? For example, Scopus.
(0) 讚! | Vincent H.

作者: 向往有你一方


領域: 环境科学与生态学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-25 03:18:03 評論於
Clarivate Analytics, alas, let's not play anymore.
(0) 讚! | 向往有你一方

作者: ID518


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 22:52:23 評論於
Web of Science
(0) 讚! | ID518

作者: xxx636


領域: 农林科学
審稿時間: 12.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-24 21:51:17 評論於
Just passing by, the eLife being on hold can be understandable, what does it mean for Science Citation Index? Is Clarivate a bit off track?
(5) 讚! | xxx636

作者: lxy


領域: 工程技术
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 21:19:34 評論於
Where did you check the status of the journal?
(0) 讚! | lxy

作者: ID518


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 20:27:48 評論於
Just found out that Elife is on hold until 2024-10-24. Does anyone know what's going on? Is it a new review process?
(1) 讚! | ID518

作者: 是志丹吖


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 12:41:16 評論於
Breaking news, the top journal in the Chinese Academy of Sciences Area 1, the renowned life science journal eLife (IF 6.4), has been officially put "On hold" by Clarivate Analytics!
(0) 讚! | 是志丹吖

作者: 震雷博超


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 18:03:03 評論於
Research focus: cancer biology
Experience sharing: eLife is on hold, could it be related to its peer review process?
(0) 讚! | 震雷博超

作者: 黑山珠佩


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-17 23:29:31 評論於
Yes.
(0) 讚! | 黑山珠佩

作者: 风满元枫


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-25 21:46:16 評論於
How is your article doing now under editorial assessment? How long has it been?
(0) 讚! | 风满元枫

作者: 冰鸟爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-25 15:00:00 評論於
The same results as yours, the editor decided to write that the work is very interesting, but the current results are preliminary, and I need to supplement long-term follow-up results and increase testing items.
(0) 讚! | 冰鸟爱

作者: 雁翠小哥哥


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-22 19:48:43 評論於
Same question.
(0) 讚! | 雁翠小哥哥

作者: KAIXINTIEQUAN


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 11:07:25 評論於
What does "Review process complete" mean after "Under editorial assessment"? Does it mean the submission has been rejected? The email said it has been considered by the editor, but priority will be given to submissions that can generate high-quality public reviews that are of significant value to the community.
(0) 讚! | KAIXINTIEQUAN

作者: KAIXINTIEQUAN


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 10:58:58 評論於
How should the reply to the submission email and the journal status be written?
(0) 讚! | KAIXINTIEQUAN

作者: 幽香绿荷


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-20 14:38:03 評論於
35 days
(0) 讚! | 幽香绿荷

作者: 幽香绿荷


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-20 13:01:53 評論於
What does the rejection reply look like? I don't understand the meaning of the email. He said it has been considered by the editors, but they will prioritize submissions that can generate high-quality public comments of significant value to the community. Is it a rejection?
(0) 讚! | 幽香绿荷

作者: Adelaide Lawson


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 22:53:16 評論於
It's not necessarily, the editor may be busy, so please be patient.
(0) 讚! | Adelaide Lawson

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/14)

開始撰寫 [eLife] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*